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INTRODUCTION
Spontaneous bacterial peritonitis (SBP), the infection of
the ascitic fluid in the absence of primary source of infection,
is a serious complication of end-stage liver disease. The preva-
lence of SBP in cirrhotic patients with ascites has been report-
ed to range between 10% and 25% (1-3). More than 60%
of such infections are due to enteric Gram-negative bacteria,
mainly Enterobacteriaceae (4). Some of recent studies, how-
ever, showed an increased incidence of Gram-positive bacterial
infections. Moreover, Staphylococcus aureus is increasingly recog-
nized as an important pathogen in hospitalized cirrhotic pa-
tients (5, 6). 
For the past 20 yr, the prognosis of cirrhotic patients with
SBP has improved greatly because of early recognition and
effective antibiotics treatment, particularly with third gen-
eration cephalosporins. SBP, however, is still the most com-
mon cause of death along with variceal bleeding, with a mor-
tality rate between 20% and 40% (3, 6). Some factors were
known to be associated with the prognosis of SBP such as
the severity of underlying liver disease, residual renal func-
tion, variceal bleeding, and hepatic encephalopathy (1, 7-12).
It is still uncertain whether the infection acquisition sites
have an effect on the prognosis of SBP or not. 
This retrospective study was undertaken to analyze the
prognostic significance of infection acquisition sites (noso-
comial vs. community-acquired) in cirrhotic patients with
SBP. In addition, we intended to compare the clinical and
microbiological features between nosocomial and commu-
nity-acquired SBP.
MATERIALS AND METHODS
Patients identification
From 1 October 1998 through 31 August 2003, all patients
with liver cirrhosis and SBP who were admitted to Guro
Hospital, Korea University, were included in the study. We
reviewed the medical records retrospectively. A community-
acquired SBP was considered in any case to be diagnosed
during the first 72 hr of hospitalization and nosocomial SBP
when the diagnosis was established after this period.
Diagnostic criteria and antimicrobial susceptibility testing
Paracentesis was performed for all patients at the admission.
The diagnosis of SBP was based on the combination of posi-
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Prognostic Significance of Infection Acquisition Sites in Spontaneous
Bacterial Peritonitis: Nosocomial versus Community Acquired
Spontaneous bacterial peritonitis (SBP) is an ascitic fluid infection as a complication
of end stage liver disease. The outcome is related to the severity of hepatorenal func-
tion, gastrointestinal bleeding, and many others; however it is not well known whether
the infection acquisition sites have an effect on the prognosis of SBP. In order to
identify the prognostic significance of the acquisition sites, we studied 106 patients
who were diagnosed as culture positive SBP between October 1998 and August
2003. Thirty-two episodes were nosocomial and 74 were community acquired. Gram-
negative bacilli such as Escherichia coli were dominant in both of the nosocomial
and community-acquired SBPs. Despite significantly higher resistance to cefotaxime
in nosocomial isolates compared to community-acquired isolates (77.8% vs. 13.6%,
p=0.001), no difference was found regarding short or long term prognosis. Infec-
tion acquisition sites were not related to short or long term prognosis either. Shock,
gastrointestinal bleeding and renal dysfunction were related to short term progno-
sis. Only Child-Pugh class C was identified as an independent prognostic factor of
long-term survival.
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tive ascitic fluid culture and and polymorphonuclear leuko-
cyte (PMNL) count of >250 cells/ L in the absence of clini-
cal, radiological, or laboratory data suggesting secondary peri-
tonitis (4). For the organisms’ identification, ascitic fluid
specimens were placed in blood culture bottles, incubated
at 37℃for 7 days. Cultures positive specimens were subcul-
tured on specific agar plates. Antibiotic susceptibility was
determined by disk diffusion method following the National
Committee for Clinical Laboratory standard (NCCLS) guide-
line (13). Extended-spectrum  -lactamase (ESBL) produc-
ing organisms were detected by disc diffusion method using
cefotaxime (30  g) and cefotaxime/clavulanic acid (30  g/
10  g), recommended by NCCLS (13). 
Data collection
Comparative analysis was performed by data from both of
nosocomial and community-acquired SBP patients. Data for
the clinical manifestations, laboratory findings, etiology of
cirrhosis, co-morbidities, empirical antibiotics, and the fol-
lowing parameters were collected; complications, mortality
of 10 days (short-term prognosis), mortality of 6 months (long-
term prognosis). The severity of liver disease was assessed by
the Child-Pugh scoring system, in which 5-15 points are
assigned and a higher score indicates greater severity. Patients
in Child-Pugh class A have preserved liver function (5-6
points), patients in class B have mild liver dysfunction (7-9
points), and patients in class C have severe liver dysfunction
(10-15 points) (14). 
Statistical analysis
Data were analyzed with SPSS 10.0. A p-value of <0.05
was considered stastically significant. The results were report-
ed as mean±SD. The Student t-test was used to compare
quantitative data, and the chi-square test was used to com-
pare qualitative variables. With the significant prognostic
variables obtained from the univariated analysis, multivari-
ated analysis was carried out using a stepwise logistic regres-
sion model. 
RESULTS
Patient characteristics
The demographic, clinical and laboratory data at the time
of diagnosis of SBP are presented in Table 1. The study includ-
ed 106 cirrhotic patients (84 male subjects and 22 female
subjects) with mean age of 55.3 yr. Thirty-two episodes (30.2
%) were nosocomial and 74 (69.8%) were community-acqu-
ired. There was no significant difference in age and sex between
patients with community-acquired SBP and those with noso-
comial SBP. In nosocomial SBP, 8 (25.0%) subjects were in
Child-Pugh class B, and 24 (75.0%) subjects were in class
C. Likewise, 22 (29.7%) class B and 52 (70.3%) class C sub-
jects were found in community-acquired SBP. Generally, class
C was dominant and no subject was in class A. Hepatitis B
was a dominant cause of cirrhosis in both groups of patients.
Patients complained of abdominal pain, febrile sense, gas-
trointestinal bleeding, diarrhea, dyspnea, and others. Diabetes
was a more common comorbidity in patients with nosocomial
SBP than in those with community-acquired SBP (37.5%
vs. 16.2%, p=0.016). Serum creatinine, BUN, and ascitic
fluid total protein levels were higher in nosocomial SBP com-
paring to community-acquired SBP. Otherwise, there was no
significant difference between nosocomial and community-
acquired episodes regarding clinical and laboratory data. 
Causative microorganisms and antimicrobial resistance
Organisms responsible for SBP, isolated from ascitic fluid,
are shown in Table 2. Among the nosocomial SBP, 18 (56.3%)
CA, community-acquired; HBV, Hepatitis B; HCV, Hepatitis C; HCC, hepa-
tocellular carcinoma.
Nosocomial SBP
(n=32)
Variables
CA SBP
(n=74)
p
value
Age (yr; mean) 58±8.7 54±8.7 NS
Sex NS
Male 24 60
Female 8 14
Etiology NS
HBV 20 48
HCV 2 4
Alcohol 6 18
Others 4 4
Initial manifestation
Diarrhea 2 4 NS
Abdominal pain 38 44 NS
Fever 8 20 NS
Gastrointestinal bleeding 2 6 NS
Dyspnea 0 10 NS
Hepatic encephalopathy 2 8 NS
Child-Pugh classification NS
Class B    8 22
Class C 24 52
Comorbidity
Diabetes 12 12 0.016
HCC 12 18 NS
Laboratory finding
Prothrombin time (%) 47.2±13.1 38.7±13.4 NS
Serum bilirubin (mg/dL) 5.0±5.2 5.8±5.6 NS
Serum sodium (mM/L) 130±7.8 129±6.6 NS
BUN (mg/dL) 44.7±45.7 27.6±23.7 0.003
Serum creatinine (mg/dL) 2.6±2.4 1.7±1.2 0.001
Ascitic fluid PMN cell  4,641±5,276 6,045±10,929 NS
count/ L
Ascitic fluid total protein (g/L) 13.2±12.2 9.9±5.2 0.001
Table 1. Demographic, clinical and laboratory data of spontane-
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isolates were E. coli, 6 (18.8%) were Klebsiella pneumoniae, and
8 (24.9%) were the rest. The causative organisms were Enter-
obacteriaceae in 50 (67.6%) episodes of community-acquired
SBP (44 cases of E. coli, 6 cases of K. pneumoniae). E. coli was
predominant in both types of SBP (>50% of total). However,
S. aureus was not isolated in both nosocomial and communi-
ty-acquired SBPs. E. coli was isolated predominantly as desc-
ribed above, therefore we studied cefotaxime resistance and
ESBL producing rate of E. coli (Table 3). As for the nosoco-
mial SBP, the cefotaxime resistance rate was higher compar-
ing to community-acquired SBP (77.8% vs. 13.6%, p=0.001),
and ESBL producing rate was also noted higher (66.7% vs.
13.6%, p=0.007). Among cefotaxime resistant E. coli, 2 noso-
comial isolates were ESBL negative by disc diffusion method.
Cefotaxime was given to most of the patients (75% of no-
socomial SBP, 89.2% of community-acquired SBP) as an
empirical therapy. We assessed the appropriateness of empiri-
cal treatment, depending on the result of antibiotic suscep-
tibility test. The result showed that cefotaxime was rather
effective in community-acquired SBP (52, 72.2%), but it
was the opposite for nosocomial SBP (12, 37.5%); cefotaxime
was not appropriate for empirical treatment of nosocomial
SBP (p=0.05, Table 2). 
Ciprofloxacin resistance is considered to be increasing be-
cause of oral quinolone use in cirrhotic patients for preven-
tion of recurrent SBP. We compared the ciprofloxacin resis-
tance of E. coli isolates from nosocomial and community-ac-
quired SBP patients (Table 3). Ciprofloxacin resistance was
noted in 8 (44.4%) cases of nosocomial SBP, and 6 (13.6%)
of community-acquired SBP. Ciprofloxacin resistance rate
tended to be higher in cases of nosocomial SBP (p=0.017).
When it came to quinolone prophylaxis (Table 3), ciproflo-
xacin resistance rate was also higher in patients with previous
oral quinolone prophylaxis within a month (46.7% vs. 14.9%,
p=0.028). Accordingly, quinolone resistance could be consid-
ered in the treatment of nosocomial SBP and patients who
had received oral quinolone prophylaxis within a previous
month.
Prognosis and complications of SBP
We tried to identify the influence on complications and
prognosis of SBP according to the acquisition sites. We com-
pared the complications of SBP (concomitant bacteremia,
hepatic encephalopathy, shock, gastrointestinal bleeding,
renal dysfunction, and hepatic failure), 10 days mortality
(short-term prognosis), and 6 months mortality (long-term
prognosis) between nosocomial and community-acquired
SBPs. As for the complications, no significant difference was
noted, and neither 10 days nor 6 months mortality showed
any statistically significant difference (Table 2). Six months
mortality though, was relatively higher in nosocomial SBP
(p=0.07). 
Acquisition site (p=0.519) or appropriateness of empirical
antibiotic treatment (p=0.956) did not have an effect on 10
days mortality, which was rather related to some factors, reflect-
ing severity of underlying liver disease or SBP, such as con-
comitant bacteremia (p=<0.001), shock (p=<0.001), gastroin-
testinal bleeding (p=0.028), renal dysfunction (p=0.006) and
Child-Pugh class C (p=<0.001) as shown in Table 4. In the
*Others included Streptococcus pneumoniae (8), other streptococci (8),
enterococci (6), Pseudomonas aeruginosa (2), Acinetobacter bauman-
nii (6) and Aeromonas hydrophila (2); 
� Appropriateness was determined
by antibiotic susceptibility test; 
� Serum creatinine level increased 3.0 mg/
dL more than baseline value.
Nosocomial 
SBP (n=32)
Variables
CA SBP
(n=74)
p
value
Causative organisms NS
E.coli 18 44
K. pneumoniae 66
Others* 8 24
Empirical cefotaxime therapy
No. of patients 24 66 NS
Appropriateness of cefotaxime
� 12 52 0.002
Complications
Bacteremia 2 16 0.053
Hepatic encephalopathy 12 26 NS
Shock 7 12 NS
Gastrointestinal bleeding 5 8 NS
Renal failure
� 78 N S
Prognosis
10-days mortality 12 23 NS
6-months mortality 26 47 0.07
Table 2. Comparison of causative organisms, appropriateness
of empirical cefotaxime therapy, complications and prognosis
between nosocomial and community-acquired (CA) sponta-
neous bacterial peritonitis (SBP)
CA, community-acquired; ESBL, extended spectrum  -lactamase.
*Oral quinolone use within recent 1 month.
Acquisition site
Nosocomial SBP (n=18) CA SBP (n=44)
Variables
p
value
Oral quinolone prophylaxis
Yes (n=15) No (n=47)
p
value
Cefotaxime-resistance 14 (77.8%) 6 (13.6%) 0.001
ESBL production 12 (66.7%) 6 (13.6%) 0.007
Ciprofloxacin-resistance 8 (44.4%) 6 (13.6%) 0.017 7 (46.7%) 7 (14.9%) 0.028
Table 3. Antibiotic resistance (%) in E. coli isolates from spontaneous bacterial peritonitis (SBP) patients according to acquisition sites
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multivariate analysis, 3 of them were independently corre-
lated with 10 days mortality: gastrointestinal bleeding (odds
ratio=31.8), shock (odds ratio=59.1), and renal dysfunction
(odds ratio=12.1) (Table 5). Although Child-Pugh class C
(p=0.005) as well as concomitant bacteremia (p=0.052), shock
(p=0.001) and renal dysfunction (p=0.005) was closely asso-
ciated with 6 months mortality on univariate analysis (Table
4), only Child-Pugh class C was identified as an independent
prognostic factor of long-term survival (odds ratio=3.97)
(Table 5). Neither inappropriate initial, empirical antibiotic
therapy nor nosocomial episodes were found to affect long
term prognosis of SBP.
DISCUSSION
SBP is a serious complication of cirrhosis in patients who
already have the complication of ascites. Even with early diag-
nosis and prompt therapy, the mortality of an episode of SBP
is still approximately 30%, comparable to the mortality of
an episode of variceal bleeding. In this study, early SBP-in-
duced mortality rate (10 days mortality) was about the same,
with the rate of 32.1% (37.5% of nosocomial episodes vs.
29.7% of community-acquired episodes), and 67.5% of the
patients died within 6 months time.
On admission, BUN and creatinine levels were higher and
diabetes was a more common comorbidity in patients with
nosocomial SBP than in those with community-acquired SBP.
In comparison, ascitic fluid protein level was significantly
lower in community-acquired SBP than in nosocomial SBP
in our study (p=0.001). There was a chance that low protein
level might contribute to the SBP occurrence in communi-
ty stay, in which infection risk was relatively lower than in
hospital stay. In the present study, 69.8% of SBP episodes
were community-acquired infection. The results rated a bit
higher than prior reports (6, 15). Our study shows that infec-
tion acquisition sites do not have an effect on the outcome of
SBP unlike previous studies. Eleven years ago, Toledo et al.
reported that community-acquired vs. hospital-acquired peri-
tonitis independently correlate with survival (12). However,
selective intestinal decontamination was not popular, and
fluoroquinolone use was strictly restricted at the time. Fur-
thermore, their study population was confined to patients
treated with cefotaxime, so there was a chance that prognos-
tic significance might have changed. Recently, Fernandez et al.
prospectively studied the epidemiological changes of bacte-
rial infections in cirrhotic patients after invasive procedures
and norfloxacin prophylaxis; they reported that nosocomial
infections had higher hospital mortality with marked increase
of Gram positive infections, which was in comparison with
the results of this study (16). However, only one fourth of
included subjects were SBP patients in that study. Likewise,
Campillo et al. also observed that nosocomial and staphylo-
coccal infections were associated with a higher mortality rate
than community-acquired, non-staphylococcal infections (17).
They intended to evaluate the prognostic significance of iso-
*Serum creatinine level increased 3.0 mg/dL more than baseline value.
Variables Odds ratio
95% confi-
dence interval
p-value
Short-term prognosis
Shock 59.1 5.8-602.7 0.001
Renal dysfunction* 12.1 1.9-76.3 0.008
Gastrointestinal bleeding 31.8 2.9-347.3 0.005
Long-term prognosis
Child-Pugh class C 3.97 1.3-10.7 0.008
Table 5. Poor prognostic factors independently related to 10
days/6 months mortality of spontaneous bacterial peritonitis (SBP)
Variables
10-days mortality
Survivors (n=71) Deaths (n=35) p-value
6-months mortality
Survivors (n=33) Deaths (n=73) p-value
Age (yr; mean) 56±9.1 53±8.2 NS 54±8.7 56±8.9 NS
Concomitant bacteremia 4 14 <0.001 2 16 0.052
Shock 3 16 <0.001 0 19 0.001
Gastrointestinal bleeding 5 8 0.028 2 11 NS
Renal dysfunction* 5 10 0.006 0 15 0.005
Child-Pugh class C 43 33 <0.001 17 59 0.005
Nosocomial episodes 20 12 NS 6 26 0.07
Diabetes 18 6 NS 4 20 0.082
Hepatocellular carcinoma 18 12 NS 6 24 NS
Appropriateness of empirical antibiotics
� 43 21 NS 23 41 NS
Prothrombin time (%) 43.4±12.3 37.1±15.7 0.017 43.0±13.9 40.5±13.8 NS
Serum bilirubin (mg/dL) 5.5±5.8 5.6±4.9 NS 5.0±5.4 5.7±5.6 NS
Serum sodium (mM/L) 131±6.3 126±6.9 NS 131±6.3 129±7.1 NS
Ascitic fluid PMN cell count/ L 4,452±5,935 8,187±14,543 0.005 6,258±6,934 5,328±10,701 NS
Ascitic fluid total protein (g/L) 9.7±7.2 13.5±9.1 NS 9.9±5.2 11.4±9.0 NS
Table 4. Variables investigated as possible prognostic factors of spontaneous bacterial peritonitis (SBP)
*Serum creatinine level increased 3.0 mg/dL more than baseline value; 
�
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late type (infecting organisms and acquisition sites) but a few
limitations were noted to identify prognostic significance of
acquisition sites in SBP; most of the episodes were nosocomial
(93.3%), and bacteremic episodes without SBP were includ-
ed. Evans et al. observed that asymptomatic outpatients had
better prognosis than the hospitalized ones (18). Most of out-
patients however, had culture-negative neutrocytic ascites
(CNNA). Bert et al. also compared the characteristics of noso-
comial and community acquired episodes of ascitic fluid infec-
tion, but more than half of the episodes were CNNA and non-
neutrocytic bacterascites (15). We confined the diagnostic
criteria as culture positive neutrocytic ascites. This is the first
comparative study mainly designed to assess the prognostic
significance of infection acquisition sites in culture positive
SBP. 
On the other hand, residual renal function, gastrointesti-
nal hemorrhage, ascitic fluid PMNL count, serum sodium
level, bilirubin, and prothrombin time were known as prog-
nostic factors, previously (1, 8, 10, 12, 19). In the present
study, shock, gastrointestinal bleeding, and renal dysfunction
showed a significant correlation with short-term prognosis
(early mortality in hospital). The most important prognostic
factor was the hemodynamic derangement including shock
and renal impairment. Ruiz-del-Arbol et al. had also reported
that hemodynamic impairment is associated with an extremely
poor prognosis despite rapid resolution of infection (20). Un-
derlying liver function was the only independent prognostic
factor of long-term survival in SBP. 
Another important finding of this study was that empiri-
cal cefotaxime treatment did not affect the prognosis notably
in spite of high resistance rate in causative organisms of noso-
comial SBP. Traditionally, Enterobacteriaceae are known as
predominant organisms causing SBP. Some studies however,
reported that streptococci were most common in communi-
ty-acquired episodes, and others showed that S. aureus infection
is increasing in nosocomial episodes (3, 5, 15). Contrarily, we
found out that Enterobacteriaceae including E. coli and K.
pneumoniae were still predominant in both community-ac-
quired and nosocomial episodes. E. coli was isolated at more
than half of episodes, so we studied cefotaxime resistance and
ESBL producing rate of E. coli. Both cefotaxime resistance
and ESBL producing rate were significantly higher in noso-
comial SBP cases. The remarkable point is that ESBL produc-
ing rate of E. coli was 66.7% of nosocomial SBP vs. 13.6%
of community-acquired SBP. The ESBL producing rate among
E. coli in Korea increased significantly from 1% in the 1980s
to 30% in the 1990s, and nowadays it is reaching 35% (3).
Depending on above data, uniform cefotaxime therapy was
not warranted, with the need of secondary antibiotics such
as carbapenem. Inappropriate empirical antibiotic therapy
though, was not correlated with short-term prognosis of SBP
and some reported previously that cefotaxime cured SBP infec-
tion despite in vitro resistance; the efficient penetration and
greater concentration of cefotaxime in ascitic fluid may account
for this finding (12). Therefore, further study is required on
the appropriateness of empirical cefotaxime therapy in SBP.
On the other hand, ciprofloxacin resistance rate was also remar-
kably high in nosocomial SBP and patients who had received
oral quinolone prophylaxis within 1 month. Because of remar-
kable resistance rate (>20%), empirical ciprofloxacin is unrec-
ommendable to those patients.
The main limitation of the present study is that it was per-
formed retrospectively. It was observational and not random-
ized therefore further study is expected in the future. 
In conclusion, infection acquisition sites do not have a prog-
nostic significance in SBP. Prognosis is also irrelevant whether
empirical antibiotics are appropriately used or not. Though
there is not statistical significance, yet careful consideration
is required if cefotaxime can be used as an effective empiri-
cal agent in nosocomial SBP. Further study is warranted on
the appropriateness of empirical antibiotics in SBP. 
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